FUT4,CD15: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It's the GeneMedi's summary page for Target/Biomarker Introduction of CD15,FUT4. The page also collects GeneMedi's different modalities and formats products for CD15 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi's target-insight database-GM ITD database, the CD15 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Introcelluar Protein.
The product of this gene transfers fucose to N-acetyllactosamine polysaccharides to generate fucosylated carbohydrate structures. It catalyzes the synthesis of the non-sialylated antigen, Lewis x (CD15). [provided by RefSeq, Jan 2009]
|Gene Official Name||FUT4|
|Gene Alias||CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX, SSEA-1|
|Protein Sub-location||Introcelluar Protein|
|Category||Therapeutics Target, INN Index|
Pre-made CD15-specific INN-index biosimilar (antibody&conjugates)-technetium (99mTc) fanolesomab
Anti-CD15 therapeutic INN-index antibodies and conjugates are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody for drug discovery, target MOA research, cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
|Cat No.||Products Name (INN Index)||INN Name||Previous Name||Target||Format||Order|
|GMP-Bios-INN-1011||Pre-Made Technetium (99Mtc) Fanolesomab Biosimilar, Radiolabelled Antibody, Anti-Cd15 Antibody: Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1 therapeutic antibody||technetium (99mTc) fanolesomab||CD15||Radiolabelled antibody|
Pre-made anti-CD15 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research.
Pre-made anti-CD15 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-CD15 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
|Cat No.||Antibody Name||Format||Classified by tag||Order|
|GM-Tg-hg-IP0027-Ab||Anti-CD15/FUT4 monoclonal antibody||mab||Therapeutics Target antibody|